Associated risk factors of lower limb lymphedema after treatment of cervical and endometrial cancer
Open Access
- 13 October 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (6) , 1
Abstract
The scope of the study was to identify the associated risk factors of lower limb lymphedema development in cervical and endometrial cancer patients. We retrospectively analysed 326 patients: 186 cases (57.06%) with cervical cancer and 140 cases (42.94%) with endometrial cancer were treated in Surgery, Radiotherapy, Oncology and Gynaecology Clinics of ‘St. Apostle Andrew’ Emergency Clinical Hospital Galati over 9 years. Adjuvant radiotherapy was performed in 83.57% of endometrial cancer cases. Adjuvant chemotherapy was performed in 45.16% of cervical cancer cases. Over 10 lymph nodes were removed in 74.73% of cervical cancer patients. Incidence of lymphedema was 15.05% in cervical cancer patients and 10% in endometrial cancer patients, P=0.06. Analysed risk factors for lower limb lymphedema occurrence were: Age, disease stage, radiotherapy, number of invaded lymph nodes (for cervical cancer patients), number of removed lymph nodes (for cervical cancer patients) and obesity. Multivariate analysis for associated risk factors of lower limb lymphedema development in cervical cancer showed that number of removed lymph nodes, OR=2.109 (0.907‑4.903), P<0.0001, number of lymph nodes with metastasis, OR=1.903 (0.253‑4.332), P=0.004 and obesity, OR=1.713 (0.226‑2.967), P=0.006 were found as statistically significant risk factors for lower limb lymphedema onset. For endometrial cancer patients, obesity, OR=1.518 (0.721‑2.75), P=0.0003, was the only associated risk factor with statistical significance for the lower limb lymphedema development. Lower limb lymphedema represents one of the adverse reactions of multimodal treatment in gynaecological cancers which affects patient's quality of life. Lower limb lymphedema occurrence is related with number of risk factors, the most important being removed lymph nodes, obesity and radiotherapy.Keywords
This publication has 17 references indexed in Scilit:
- NADPH OXIDASE: STRUCTURE AND ACTIVATION MECHANISMS (REVIEW). NOTE I.2016
- Lower Limb Lymphedema and Neurological Complications After Lymphadenectomy for Gynecological CancerInternational Journal of Gynecological Cancer, 2015
- Incidence and Risk Factors of Lower-Extremity Lymphedema After Radical Surgery With or Without Adjuvant Radiotherapy in Patients With FIGO Stage I to Stage IIA Cervical CancerInternational Journal of Gynecological Cancer, 2012
- Risk factors for lower-limb lymphedema after surgery for cervical cancerInternational Journal of Clinical Oncology, 2011
- Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinomaBMC Cancer, 2009
- Lymph Edema of the Lower Extremities after Lymphadenectomy and Radiotherapy for Cervical CancerStrahlentherapie und Onkologie, 2008
- The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer CenterGynecologic Oncology, 2006
- Lymphedema and Lymphocysts Following Lymphadenectomy May Be Prevented by Omentoplasty: A Pilot StudyGynecologic Oncology, 1999
- Pelvic lymphocyst—A 10-year experienceGynecologic Oncology, 1988
- SELECTION OF APPROPRIATE SURGICAL PROCEDURES IN LYMPHEDEMAPlastic and Reconstructive Surgery, 1962